These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 884924)

  • 61. A pharmacokinetic study of adriamycin and 4'epi-adriamycin after simultaneous intra-arterial liver administration.
    Eksborg S; Andersson M; Domellöf L; Lönroth U
    Med Oncol Tumor Pharmacother; 1986; 3(2):105-10. PubMed ID: 3462442
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sorbent removal of adriamycin in vitro and in vivo.
    Winchester JF; Rahman A; Tilstone WJ; Kessler A; Mortensen L; Schreiner GE; Schein PS
    Cancer Treat Rep; 1979; 63(11-12):1787-93. PubMed ID: 526913
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Combination chemotherapy with adriamycin and streptozotocin. II. Clincopharmacologic correlation of augmented adriamycin toxicity caused by streptozotocin.
    Chang P; Riggs CE; Scheerer MT; Wiernik PH; Bachur NR
    Clin Pharmacol Ther; 1976 Nov; 20(5):611-6. PubMed ID: 135667
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of verapamil on the pharmacokinetics and hepatobiliary disposition of fexofenadine in pigs.
    Sjögren E; Hedeland M; Bondesson U; Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():214-23. PubMed ID: 24075962
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patients.
    Camaggi CM; Strocchi E; Martoni A; Angelelli B; Comparsi R; Pannuti F
    Drugs Exp Clin Res; 1985; 11(4):285-94. PubMed ID: 3869807
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Drug interactions affecting the elimination of doxorubicin in the rat.
    Wosilait WD; Ryan MP
    Res Commun Chem Pathol Pharmacol; 1987 Jun; 56(3):335-48. PubMed ID: 3628964
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics of adriamycin, adriamycinol, and antipyrine in patients with moderate tumor involvement of the liver.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    J Cancer Res Clin Oncol; 1987; 113(6):593-8. PubMed ID: 2824523
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Determination of adriamycin and its fluorescent metabolites in human plasma by HPLC.
    Mahdadi R; Lhermitte M; Lafitte JJ
    Biomed Chromatogr; 1987 Feb; 2(1):38-40. PubMed ID: 3508093
    [TBL] [Abstract][Full Text] [Related]  

  • 71. No evidence of enterohepatic circulation of doxorubicin in a patient with transitory biliary obstruction due to lymphoblastic lymphoma.
    Engervall PA; Björkholm MJ; Peterson CO
    J Chemother; 1991 Aug; 3(4):264-6. PubMed ID: 1779262
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.
    Heggie GD; Sommadossi JP; Cross DS; Huster WJ; Diasio RB
    Cancer Res; 1987 Apr; 47(8):2203-6. PubMed ID: 3829006
    [TBL] [Abstract][Full Text] [Related]  

  • 73. General and cardiac toxicity of adriamycinol in rats.
    Danesi R; Del Tacca M; Della Torre P; Bernardini C
    Anticancer Res; 1986; 6(5):967-72. PubMed ID: 3800337
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver.
    Booth CL; Brouwer KR; Brouwer KL
    Cancer Res; 1998 Aug; 58(16):3641-8. PubMed ID: 9721873
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
    Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agent.
    Breda M; Benedetti MS; Battaglia R; Castelli MG; Poggesi I; Spinelli R; Hackett AM; Dostert P
    Pharmacol Res; 2000 Feb; 41(2):239-48. PubMed ID: 10623492
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reversed-phase liquid chromatography of adriamycin and daunorubicin and their hydroxyl metabolites adriamycinol and daunorubicinol.
    Eksborg S
    J Chromatogr; 1978 Feb; 149():225-32. PubMed ID: 649731
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative histochemical study of adriamycin and adriamycinol in rat liver and heart.
    Mazzanti L; Breschi MC; Scalori V; Giovannini L; Mian M
    In Vivo; 1988; 2(3-4):189-93. PubMed ID: 2979836
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A pharmacokinetic evaluation of free and DNA-complexed adriamycin: a preliminary study in children with malignant disease.
    Kummen M; Lie KK; Lie SO
    Acta Pharmacol Toxicol (Copenh); 1978 Mar; 42(3):212-8. PubMed ID: 580348
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Quantitative thin-layer chromatography: thin-film fluorescence scanning analysis of adriamycin and metabolites in tissue.
    Chan KK; Wong CD
    J Chromatogr; 1979 Apr; 172():343-9. PubMed ID: 548536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.